Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
This Quarter Return
+6.68%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$17.7B
AUM Growth
+$17.7B
Cap. Flow
+$1.12B
Cap. Flow %
6.33%
Top 10 Hldgs %
32.89%
Holding
1,376
New
56
Increased
736
Reduced
284
Closed
54

Sector Composition

1 Real Estate 45.9%
2 Technology 16.73%
3 Consumer Discretionary 5.58%
4 Communication Services 5.5%
5 Financials 5.27%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ALXO icon
1251
ALX Oncology
ALXO
$54.6M
$2K ﹤0.01%
138
ANAB icon
1252
AnaptysBio
ANAB
$630M
$2K ﹤0.01%
105
ARQT icon
1253
Arcutis Biotherapeutics
ARQT
$1.91B
$2K ﹤0.01%
245
AVXL icon
1254
Anavex Life Sciences
AVXL
$817M
$2K ﹤0.01%
314
BMEA icon
1255
Biomea Fusion
BMEA
$114M
$2K ﹤0.01%
109
CGEM icon
1256
Cullinan Oncology
CGEM
$456M
$2K ﹤0.01%
127
CNTA
1257
Centessa Pharmaceuticals
CNTA
$2.13B
$2K ﹤0.01%
211
COGT icon
1258
Cogent Biosciences
COGT
$1.83B
$2K ﹤0.01%
281
CSTL icon
1259
Castle Biosciences
CSTL
$673M
$2K ﹤0.01%
86
CVAC icon
1260
CureVac
CVAC
$1.21B
$2K ﹤0.01%
697
EOLS icon
1261
Evolus
EOLS
$477M
$2K ﹤0.01%
162
GLPG icon
1262
Galapagos
GLPG
$2.06B
$2K ﹤0.01%
51
ITOS
1263
DELISTED
iTeos Therapeutics
ITOS
$2K ﹤0.01%
121
KALV icon
1264
KalVista Pharmaceuticals
KALV
$713M
$2K ﹤0.01%
+154
New +$2K
ME
1265
DELISTED
23andMe Holding Co. Class A Common Stock
ME
$1K ﹤0.01%
956
XERS icon
1266
Xeris Biopharma Holdings
XERS
$1.27B
$1K ﹤0.01%
404
VTYX icon
1267
Ventyx Biosciences
VTYX
$184M
$1K ﹤0.01%
228
VNDA icon
1268
Vanda Pharmaceuticals
VNDA
$279M
$1K ﹤0.01%
191
URGN icon
1269
UroGen Pharma
URGN
$896M
$1K ﹤0.01%
48
ABUS icon
1270
Arbutus Biopharma
ABUS
$753M
$1K ﹤0.01%
395
AMLX icon
1271
Amylyx Pharmaceuticals
AMLX
$877M
$1K ﹤0.01%
266
AMRN
1272
Amarin Corp
AMRN
$311M
$1K ﹤0.01%
1,336
ATAI icon
1273
ATAI Life Sciences
ATAI
$969M
$1K ﹤0.01%
468
AVIR icon
1274
Atea Pharmaceuticals
AVIR
$275M
$1K ﹤0.01%
242
CHRS icon
1275
Coherus Oncology, Inc. Common Stock
CHRS
$146M
$1K ﹤0.01%
262